Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Jianzhong Huang
Introduction
Jianzhong Huang is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods. His work focuses on utilizing vascular endothelial growth factor (VEGF) inhibitors to combat tumors effectively.
Latest Patents
Jianzhong Huang holds a patent for a method of tumor regression with VEGF inhibitors. This patent describes methods of regressing or inhibiting a tumor in a subject by administering an agent capable of blocking, inhibiting, or ameliorating VEGF-mediated activity. The method results in a reduction of tumor size and inhibition of tumor metastases, making it particularly useful for patients suffering from bulky, metastatic cancers. He has 1 patent to his name.
Career Highlights
Huang is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to advance his research in oncology. His work has garnered attention for its potential to improve treatment outcomes for cancer patients.
Collaborations
Some of his notable coworkers include Jessica Kandel and Jocelyn Holash, who collaborate with him on various projects within the company.
Conclusion
Jianzhong Huang's innovative approach to cancer treatment through VEGF inhibitors showcases his dedication to improving patient care. His contributions to the field are invaluable and highlight the importance of ongoing research in medical science.